Barriers to physician adherence to evidence-based monitoring guidelines in chronic myelogenous leukemia

Journal of Oncology Practice
Stuart L GoldbergAndrew L Pecora

Abstract

Although monitoring of cytogenetic/molecular responses to therapy in chronic myelogenous leukemia (CML) facilitates superior outcomes, less than one half of CML patients are monitored using published evidence-based guidelines. Barriers to physician adherence with guidelines are unknown. An anonymous survey was mailed to 515 hematologist-oncologists in New Jersey and Indiana exploring attitudes toward monitoring guidelines. Ninety-six physicians (19%) responded-89% in community practice, 83% with more than 10 years of experience, and 92% caring for CML patients. Eighty-four percent self-reported using CML monitoring guidelines, 14% were familiar with but did not adopt guidelines and 2% were unfamiliar. Eighty-four percent performed molecular monitoring quarterly as recommended; 6% did not perform molecular monitoring at all during the first year. Guidelines were considered evidence based by 98%, but only 54% strongly considered them easy to find; only 51% strongly felt they addressed all aspects of disease management. Patient resource barriers were a significant deterrent toward implementation with 30% citing high costs. Physician resources, including lack of time to search guidelines, limited use in one fifth. Despite 90% belie...Continue Reading

References

Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Mar 10, 2005·JAMA : the Journal of the American Medical Association·Amit X GargR Brian Haynes
Aug 23, 2005·International Journal of Technology Assessment in Health Care·Bernard S Bloom
Jul 5, 2008·Annals of Surgical Oncology·Jennifer Erickson FosterTina J Hieken
Dec 22, 2010·Archives of Otolaryngology--head & Neck Surgery·Carol M LewisRandal S Weber
Nov 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David MarinLetizia Foroni
Feb 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ryaz ChagparJanice N Cormier
Jul 6, 2012·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Brendan C VisserKim F Rhoads
Nov 6, 2013·Journal of Medical Economics·Annie GuérinStuart L Goldberg
Nov 15, 2013·Journal of the National Comprehensive Cancer Network : JNCCN·Susan O'BrienUNKNOWN Ntational comprehensive cancer network
Dec 25, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stacie B DusetzinaNancy L Keating

❮ Previous
Next ❯

Citations

Oct 5, 2015·Clinical Lymphoma, Myeloma & Leukemia·Stuart L Goldberg
Apr 18, 2016·Journal of Cancer Research and Clinical Oncology·Qian Jiang, Robert Peter Gale
Apr 10, 2016·American Journal of Hematology·Daniel Egan, Jerald Radich
Jul 16, 2016·Healthcare·Florian FischerAlexander Kraemer
Aug 6, 2010·Critical Reviews in Oncology/hematology·Massimo Breccia, Giuliana Alimena
Jan 23, 2019·Leukemia & Lymphoma·Geneviève I C G EctorNicole M A Blijlevens
Aug 2, 2019·The International Journal of Health Planning and Management·Jianwei ShiZhaoxin Wang
Sep 23, 2018·Journal of Global Oncology·Uday YanamandraSubhash Varma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.